NeuroPace (NPCE) Revenue & Revenue Breakdown
NeuroPace Revenue Highlights
Latest Revenue (Y)
$79.91M
Latest Revenue (Q)
$21.06M
Main Geography (Y)
Non-US
NeuroPace Revenue by Period
NeuroPace Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $79.91M | 22.14% |
| 2023-12-31 | $65.42M | 43.72% |
| 2022-12-31 | $45.52M | 0.75% |
| 2021-12-31 | $45.18M | 9.83% |
| 2020-12-31 | $41.14M | 11.27% |
| 2019-12-31 | $36.97M | - |
NeuroPace generated $79.91M in revenue during NA 2024, up 22.14% compared to the previous quarter, and up 216.13% compared to the same period a year ago.
NeuroPace Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $21.06M | 9.37% |
| 2024-06-30 | $19.26M | 6.25% |
| 2024-03-31 | $18.12M | 0.62% |
| 2023-12-31 | $18.01M | 9.65% |
| 2023-09-30 | $16.43M | -0.50% |
| 2023-06-30 | $16.51M | 14.08% |
| 2023-03-31 | $14.47M | 13.16% |
| 2022-12-31 | $12.79M | 14.63% |
| 2022-09-30 | $11.16M | 9.38% |
| 2022-06-30 | $10.20M | -10.32% |
| 2022-03-31 | $11.37M | 3.43% |
| 2021-12-31 | $11.00M | 6.36% |
| 2021-09-30 | $10.34M | -18.14% |
| 2021-06-30 | $12.63M | 12.60% |
| 2021-03-31 | $11.22M | 4.32% |
| 2020-12-31 | $10.75M | -15.81% |
| 2020-09-30 | $12.77M | 67.16% |
| 2020-06-30 | $7.64M | -23.41% |
| 2020-03-31 | $9.97M | - |
NeuroPace generated $21.06M in revenue during Q3 2024, up 9.37% compared to the previous quarter, and up 127.56% compared to the same period a year ago.
NeuroPace Revenue Breakdown
NeuroPace Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 |
|---|---|---|
| Non-US | $200.00K | $100.00K |
Latest
NeuroPace's latest annual revenue breakdown by geography, as of Dec 24: Non-US (100.00%).
NeuroPace Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.72B | $746.27M |
| CNMD | CONMED | $1.31B | $316.70M |
| NVRO | Nevro | $408.52M | $104.16M |
| AORT | Artivion | $388.54M | $95.78M |
| GKOS | Glaukos | $383.48M | $96.67M |
| FNA | Paragon 28 | $256.18M | $61.02M |
| KIDS | OrthoPediatrics | $204.73M | $52.80M |
| ANIK | Anika Therapeutics | $166.66M | $38.75M |
| SRDX | Surmodics | $126.08M | $29.92M |
| LUNG | Pulmonx | $83.79M | $20.39M |
| NPCE | NeuroPace | $79.91M | $21.06M |
| IRMD | IRadimed | $73.24M | $18.33M |
| CVRX | CVRx | $51.29M | $13.37M |
| OFIX | Orthofix Medical | - | $198.62M |